Advertisement
Screener

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

TEVA PHARMACEUTICAL INDUSTRIES LIMITED Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $35.86 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-02-03

  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $35.86, a 5.07% increase from fiscal 2024.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $34.13, a 1.50% decline from fiscal 2023.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $34.65, a 2.61% increase from fiscal 2022.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $33.77, a 6.43% decline from fiscal 2021.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month
2025-12-31$35.86
10-K · filed 2026-02-03
2024-12-31$34.13
10-K · filed 2026-02-03
2023-12-31$34.65
10-K · filed 2026-02-03
2022-12-31$33.77
10-K · filed 2025-02-05
2021-12-31$36.09
10-K · filed 2024-02-12
2020-12-31$40.24
10-K · filed 2023-02-10
2019-12-31$42.12
10-K · filed 2022-02-09
2018-12-31$39.38
10-K · filed 2021-02-10
2017-12-31$47.92
10-K · filed 2020-02-21
2016-12-31$54.09
10-K · filed 2019-02-19